Skip to content
mp.weixin.qq.com· 百善阳光老人·· 18 days agoPickScore50

FDA Approves New Drug That Extends Survival in Pancreatic Cancer

美国食品和药物管理局批准突破性胰腺癌药物

In brief

The FDA has approved a new drug for pancreatic cancer that reportedly extends survival in patients. The approval was reported by Scientific American on August 26 and relayed by Chinese industry media on August 29. No drug name, trial details or dosing information were given in the report.

Why it matters

FDA approval of a new pancreatic cancer drug is relevant to clinicians despite sparse detail.

Source: mp.weixin.qq.com · mp.weixin.qq.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org